Investigators explored the characteristics of patients with geographic atrophy who experienced varying degrees of vision loss ...

Myopia control efforts using NVK002 0.01% atropine exceeds the performance of a placebo, according to research presented at ...

Complications, including pseudoexfoliation (ARR 5.7), zonular dialysis (ARR 3.3), posterior capsule rupture (PCR) (ARR 16.4), ...

A poster presentation explored the potential of VRDN-001 for reducing proptosis in patients with thyroid eye disease.

Researchers evaluated the predictive effect of baseline 24-hour blood pressure on visual field loss in patients with glaucoma ...

NT-501 implantation in patients with macular telangiectasia type 2 (MacTel2) is well-tolerated and correlates with a lower ...

Patients undergoing hormone replacement therapy and long-term estrogen treatments appear to have a lower risk of glaucoma ...

A real-world faricimab study shows that, for some with nAMD, 3 loading doses, rather than 4, can be sufficient.

Findings showed the study met its primary endpoint demonstrating a reduction in disability accumulation with tolebrutinib ...

Lithium aspartate is not effective for neurologic post-COVID-19 condition (PCC) symptoms of fatigue and cognitive dysfunction ...

Diabetic retinopathy lesions type and severity can provide prognostic details about a patients’ risk of progression.

A dry AMD treatment that uses a low-level light therapy device is safe, well-tolerated, and may offer functional and anatomical improvements.